Subsection h (Items 1405(a) and                1            0.25            0.25            $300            $300
 (b) of S-K)....................
----------------------------------------------------------------------------------------------------------------
Form F-4........................  ..............  ..............             1.0  ..............          $1,200
----------------------------------------------------------------------------------------------------------------
Subsection a (Item 1402 of S-K).               2            0.25             0.5            $300            $600
Subsection b (Item 1403 of S-K).               0               0               0               0              $0
Subsection c (Item 1404 of S-K).               2            0.25             0.5            $300            $600
Subsection d (Item 1405(c) of S-               0               0               0               0              $0
 K).............................
Subsection e (Item 1406 of S-K).               2            0.25             0.5            $300            $600
Subsection f (Item VI of Guide                 2          (0.25)           (0.5)          ($300)          ($600)
 3).............................
Subsection g (Item 1402 of S-K).               2          (0.25)           (0.5)          ($300)          ($600)
Subsection h (Items 1405(a) and                2            0.25             0.5            $300            $600
 (b) of S-K)....................
----------------------------------------------------------------------------------------------------------------
Form 10.........................  ..............  ..............             1.0  ..............          $1,200
----------------------------------------------------------------------------------------------------------------
Subsection a (Item 1402 of S-K).               2            0.25             0.5            $300            $600
Subsection b (Item 1403 of S-K).               0               0               0               0              $0
Subsection c (Item 1404 of S-K).               2            0.25             0.5            $300            $600
Subsection d (Item 1405(c) of S-               0               0               0               0              $0
 K).............................
Subsection e (Item 1406 of S-K).               2            0.25             0.5            $300            $600
Subsection f (Item VI of Guide                 2          (0.25)           (0.5)          ($300)          ($600)
 3).............................
Subsection g (Item 1402 of S-K).               2          (0.25)           (0.5)          ($300)          ($600)
Subsection h (Items 1405(a) and                2            0.25             0.5            $300            $600
 (b) of S-K)....................
----------------------------------------------------------------------------------------------------------------
Form 1-A........................  ..............  ..............             1.5  ..............          $1,200
----------------------------------------------------------------------------------------------------------------
Subsection a (Item 1402 of S-K).               1            0.75            0.75            $600            $600
Subsection b (Item 1403 of S-K).               0               0               0              $0              $0
Subsection c (Item 1404 of S-K).               1            0.75            0.75            $600            $600
Subsection d (Item 1405(c) of S-               0               0               0              $0              $0
 K).............................
Subsection e (Item 1406 of S-K).               1            0.75            0.75            $600            $600
Subsection f (Item VI of Guide                 1          (0.75)          (0.75)          ($600)          ($600)
 3).............................
Subsection g (Item 1402 of S-K).               1          (0.75)          (0.75)          ($600)          ($600)
Subsection h (Items 1405(a) and                1            0.75            0.75            $600            $600
 (b) of S-K)....................
----------------------------------------------------------------------------------------------------------------
    Total.......................  ..............  ..............           2,842  ..............        $529,200
----------------------------------------------------------------------------------------------------------------

v. Total Paperwork Burden Under the Final Rules
    Table 13 below shows the total estimated internal burden hours and
costs for outside professional under the final rules.\241\
---------------------------------------------------------------------------

    \241\ Figures in the table have been rounded to the nearest
whole number.
---------------------------------------------------------------------------

                                                 Table 13--Total Paperwork Burden Under the Final Rules
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Change in       Change in
                                      Current annual      Current        Current cost       internal         outside      Burden hours      Costs for
                                         responses     burden hours         burden         registrant     professional    for affected       affected
                                                                                burden hours        costs         responses       responses
                                                 (A)             (B)                (C)             (D)             (E)      (F) [(B) +  (G) [(C) + (E)]
                                                                                (D)]
--------------------------------------------------------------------------------------------------------------------------------------------------------
10-K................................           8,137      14,198,780     $1,895,224,719           2,700        $360,000      14,201,480   $1,895,584,719
20-F................................             725         479,304        576,875,025              87         103,800         479,391      576,978,825
S-1.................................             901         147,208        180,319,975               8           9,000         147,216      180,328,975
S-4.................................             551         562,465        677,378,579              44          52,200         562,509      677,430,779
F-1.................................              63          26,692         32,275,375               1             600          26,693       32,275,975
F-4.................................              39          14,049         17,073,825               1           1,200          14,050       17,075,025
10..................................             216          11,855         14,091,488               1           1,200          11,856       14,092,688
1-A.................................             179          98,396         13,111,912               2           1,200          98,398       13,113,112
--------------------------------------------------------------------------------------------------------------------------------------------------------

IX. Regulatory Flexibility Act Certification

    The Commission certified, under section 605(b) of the Regulatory
Flexibility Act (``RFA''), that, when adopted, the proposed amendments
to the rules would not have a significant economic impact on a
substantial number of small entities. This certification, including our
basis for the certification, was set forth in Section IX of the
Proposing Release. The Commission solicited comments regarding this
certification and received no comments. We continue to believe this
certification is appropriate. As noted in the Proposing Release, the
Commission identified only one issuer that potentially would be subject
to the proposed amendments and that may be considered a small entity.
In addition, the proposed rules would have resulted in only modest
effects on registrants' compliance burdens, for example, by adding
between six additional burden hours for annual reports and one
additional burden hour for registration statements (initial or
otherwise). We also do not believe the proposed rules would otherwise
have a significant economic effect on any small entities.
    We are adopting the final rules as proposed with one substantive
change relating to the proposed new credit ratio disclosure
requirements. We do not believe that this change, which as discussed
above will further limit the registrant's compliance burdens, alters
the basis upon which the certification in the Proposing Release was
made. Accordingly, we certify that the final rules will not have a
significant economic impact on a substantial number of small entities.

X. Statutory Authority

    The amendments contained in this release are being adopted under
the authority set forth in Sections 3(b), 7, 10, 19(a), and 28 of the
Securities Act and Sections 3(b), 12, 13, 15(d), 23(a), and 36(a) of
the Exchange Act.

List of Subjects

17 CFR Part 210

    Accountants, Accounting, Banks, Banking, Employee benefit plans,
Holding companies, Insurance companies, Investment companies, Oil and
gas exploration, Reporting and recordkeeping requirements, Securities,
Utilities.

17 CFR Part 229

    Reporting and recordkeeping requirements, Securities.

17 CFR Part 249

    Brokers, Reporting and recordkeeping requirements, Securities.

    In accordance with the foregoing, Title 17, Chapter II of the Code
of Federal Regulations is amended as follows:

PART 210--FORM AND CONTENT OF AND REQUIREMENTS FOR FINANCIAL
STATEMENTS, SECURITIES ACT OF 1933, SECURITIES EXCHANGE ACT OF
1934, INVESTMENT COMPANY ACT OF 1940, INVESTMENT ADVISERS ACT OF
1940, AND ENERGY POLICY AND CONSERVATION ACT OF 1975

0
1. The authority citation for part 210 continues to read as follows:

    Authority: 15 U.S.C. 77f, 77g, 77h, 77j, 77s, 77z-2, 77z-3,
77aa(25), 77aa(26), 77nn(25), 77nn(26), 78c, 78j-1, 78l, 78m, 78n,
78o(d), 78q, 78u-5, 78w, 78ll, 78mm, 80a-8, 80a-20, 80a-29, 80a-30,
80a-31, 80a-37(a), 80b-3, 80b-11, 7202 and 7262, and sec. 102(c),
Pub. L. 112-106, 126 Stat. 310 (2012), unless otherwise noted.

0
2. Revise Sec.  210.9-01 to read as follows:

Sec.  210.9-01  Application of Sec. Sec.  210.9-01 to 210.9-07

    The consolidated financial statements filed for bank holding
companies, savings and loan holding companies, and the financial
statements of banks and savings and loan associations, must apply the
guidance in this article in filings with the Commission.

0
3. Amend Sec.  210.9-03 by:
0
a. Removing and reserving paragraphs 7(a) through (c); and
0
b. revising paragraph 7(e)(2).
    The revisions to read as follows:

Sec.  210.9-03  Balance sheets.

* * * * *
    7. * * *
    (e) * * *
    (2) If a significant portion of the aggregate amount of loans
outstanding at the end of the fiscal year disclosed pursuant to
(e)(1)(i) above relates to loans that are disclosed as past due,
nonaccrual or troubled debt restructurings in the consolidated
financial statements, so state and disclose the aggregate amounts of
such loans along with such other information necessary to an
understanding of the effects of the transactions on the financial
statements.
* * * * *

PART 229--STANDARD INSTRUCTIONS FOR FILING FORMS UNDER SECURITIES
ACT OF 1933, SECURITIES EXCHANGE ACT OF 1934 AND ENERGY POLICY AND
CONSERVATION ACT OF 1975--REGULATION S-K

0
3. The authority citation for part 229 continues to read as follows:

    Authority: 15 U.S.C. 77e, 77f, 77g, 77h, 77j, 77k, 77s, 77z-2,
77z-3, 77aa(25), 77aa(26), 77ddd, 77eee, 77ggg, 77hhh, 77iii, 77jjj,
77nnn, 77sss, 78c, 78i, 78j, 78j-3, 78l, 78m, 78n, 78n-1, 78o, 78u-
5, 78w, 78ll, 78 mm, 80a-8, 80a-9, 80a-20, 80a-29, 80a-30, 80a-
31(c), 80a-37, 80a-38(a), 80a-39, 80b-11 and 7201 et seq.; 18 U.S.C.
1350; sec. 953(b), Pub. L. 111-203, 124 Stat. 1904 (2010); and sec.
102(c), Pub. L. 112-106, 126 Stat. 310 (2012).

0
4. Amend Sec.  229.404 by revising Instruction 4.c under ``Instructions
to Item 404(a)'' to read as follows:

Sec.  229.404  (Item 404) Transactions with Related Persons, Promoters
and Certain Control Persons

* * * * *
    Instructions to Item 404(a)
* * * * *
    4. * * *
    c. If the lender is a bank, savings and loan association, or
broker-dealer extending credit under Federal Reserve Regulation T (12
CFR part 220) and the loans are not disclosed as past due, nonaccrual
or troubled debt restructurings in the consolidated financial
statements, disclosure under paragraph (a) of this Item may consist of
a statement, if such is the case, that the loans to such persons:
    i. Were made in the ordinary course of business;
    ii. Were made on substantially the same terms, including interest
rates and collateral, as those prevailing at the time for comparable
loans with persons not related to the lender; and
    iii. Did not involve more than the normal risk of collectibility or
present other unfavorable features.
* * * * *

Sec.  229.801  [Amended]

0
5. Amend Sec.  229.801 by removing and reserving paragraph (c).

Sec.  229.802  [Amended]

0
6. Amend Sec.  229.802 by removing and reserving paragraph (c).

0
7. Add subpart 229.1400, consisting of Sec. Sec.  229.1400 through
229.406, to read as follows:

Subpart 229.1400--Disclosure by Bank and Savings and Loan
Registrants

Sec.

229.1401 (Item 1401) General instructions.
229.1402 (Item 1402) Distribution of assets, liabilities and
stockholders' equity; interest rates and interest differential.
229.1403 (Item 1403) Investments in debt securities.
229.1404 (Item 1404) Loan portfolio.
229.1405 (Item 1405) Allowance for Credit Losses.
229.1406 (Item 1406) Deposits.

Sec.  229.1401  (Item 1401) General instructions.

    (a) A bank, bank holding company, savings and loan association, or
savings and loan holding company (``bank and savings and loan
registrants'') must provide the disclosure required by this subpart.
    (b) When the term ``reported period'' is used in this subpart, it
refers to each of the periods described below:
    (1) Each annual period required by 17 CFR part 210 (``Regulation S-
X'') or 17 CFR 239.90 (``Form 1-A''); and--
    (2) Any additional interim period subsequent to the most recent
fiscal year end if a material change in the information or the trend
evidenced thereby has occurred.
    (c) In this subpart, registrants are required to use daily averages
unless otherwise indicated. Registrants may use weekly or month-end
averages where the collection of data on a daily average basis would
involve unwarranted or undue burden or expense; provided that such
averages are representative of the registrant's operations. Registrants
must disclose the basis used for presenting averages.
    (d) In various provisions throughout this subpart, registrants are
required to disclose information relating to certain foreign financial
activities. For purposes of this subpart, a registrant only is required
to present this information if the registrant meets the threshold to
make separate disclosures concerning its foreign activities in its
consolidated financial statements pursuant to the test set forth in
Sec.  210.9-05 of Regulation S-X.

Sec.  229.1402  (Item 1402) Distribution of assets, liabilities and
stockholders' equity; interest rates and interest differential.

    (a) For each reported period, present average balance sheets
containing the information specified below. The format of the average
balance sheets may be condensed from consolidated financial statements,
provided that the condensed average balance sheets indicate the
significant categories of assets and liabilities, including all major
categories of interest-earning assets and interest-bearing liabilities.
Major categories of interest-earning assets must include, if material,
loans, taxable investment securities, non-taxable investment
securities, interest bearing deposits in other banks, federal funds
sold, securities purchased with agreements to resell, and other short-
term investments. Major categories of interest-bearing liabilities must
include, if material, savings deposits, other time deposits, federal
funds purchased, securities sold under agreements to repurchase,
commercial paper, other short-term debt, and long-term debt.
    (b) For each reported period, present an analysis of net interest
earnings as follows:
    (1) For each major category of interest-earning asset and each
major category of interest-bearing liability, the average amount
outstanding during the period and the interest earned or paid on such
amount.
    (2) The average yield for each major category of interest-earning
asset.
    (3) The average rate paid for each major category of interest-
bearing liability.
    (4) The average yield on all interest-earning assets and the
average rate paid on all interest-bearing liabilities.
    (5) The net yield on interest-earning assets (net interest earnings
divided by total interest-earning assets, with net interest earnings
equaling the difference between total interest earned and total
interest paid).
    (6) The registrant may, at its option, present its analysis in
connection with the average balance sheet required by paragraph (a) of
this section.
    (c) For the interest rates and interest differential analysis,
    (1) Present for each comparative reporting period
    (i) The dollar amount of change in interest income, and
    (ii) The dollar amount of change in interest expense.
    (2) For each major category of interest-earning asset and interest-
bearing liability, segregate the changes presented pursuant to
paragraph (c)(1) of this section into amounts attributable to:
    (i) Changes in volume (change in volume times old rate),
    (ii) Changes in rates (change in rate times old volume), and
    (iii) Changes in rates and volume (change in rate times change in
volume).
    (3) The rates and volume variances presented pursuant to paragraph
(c)(2) must be allocated on a consistent basis between rates and volume
variances, and the basis of allocation disclosed in a note to the
table.
    Instructions to Item 1402:
    1. If material, disclose how non-accruing loans have been treated
for purposes of the analyses required by paragraph (b).
    2. In the calculation of the changes in the interest income and
interest expense required by paragraph (c), exclude any out-of-period
items and adjustments and disclose the types and amounts of items
excluded in a note to the table.
    3. If material loan fees are included in the interest income
computation, disclose the amount of such fees.
    4. If tax-exempt income is calculated on a tax equivalent basis,
describe the extent of recognition of exemption from Federal, state,
and local taxation and the combined marginal or incremental rate used
in a brief note to the table.
    5. If disclosure regarding foreign activities is required pursuant
to Item 1401(d) of this subpart, the information required by paragraphs
(a), (b) and (c) of this section must be further segregated between
domestic and foreign activities for each significant category of assets
and liabilities disclosed pursuant to paragraph (a). In addition, for
each reported period, present separately, on the basis of averages, the
percentage of total assets and total liabilities attributable to
foreign activities.

Sec.  229.1403  (Item 1403) Investments in debt securities.

    (a) As of the end of the latest reported period, state the weighted
average yield of each category of debt securities not carried at fair
value through earnings for which disclosure is required in the
financial statements and is due:
    (1) In one year or less,
    (2) After one year through five years,
    (3) After five years through ten years, and
    (4) After ten years.
    (b) Disclose how the weighted average yield has been calculated.
Additionally, state whether yields on tax-exempt obligations have been
computed on a tax-equivalent basis (see Instruction 4 to Item 1402 of
this subpart). Discuss any major changes in the tax-exempt portfolio.

Sec.  229.1404  (Item 1404) Loan portfolio.

    (a) As of the end of the latest reported period, present separately
the amount of loans in each category for which disclosure is required
in the financial statements that are due:
    (1) In one year or less,
    (2) After one year through five years,
    (3) After five years through 15 years, and
    (4) After 15 years.
    (b) For each loan category for which disclosure is provided in
response to paragraph (a), present separately the total amount of loans
in such loan category that are due after one year that
    (1) Have predetermined interest rates and

    (2) Have floating or adjustable interest rates.
    Instructions to Item 1404:
    1. Report scheduled repayments in the maturity category in which
the payment is due.
    2. Report demand loans, loans having no stated schedule of
repayments and no stated maturity, and overdrafts as due in one year or
less.
    3. Determinations of maturities shall be based upon contractual
terms. However, to the extent that non-contractual rollovers or
extensions are included for purposes of measuring the allowance for
credit losses under U.S. GAAP or IFRS, include such non-contractual
rollovers or extensions for purposes of the maturities classification
and briefly discuss this methodology.

Sec.  229.1405  (Item 1405) Allowance for Credit Losses.

    (a) For each reported period, disclose the following credit ratios,
along with each component of the ratio's calculation:
    (1) Allowance for credit losses to total loans outstanding at each
period end.
    (2) Nonaccrual loans to total loans outstanding at each period end.
    (3) Allowance for credit losses to nonaccrual loans at each period
end.
    (4) Net charge-offs during the period to average loans outstanding
during the period. Provide this ratio for each loan category for which
disclosure is required in the financial statements.
    (b) Provide a discussion of the factors that drove material changes
in the ratios in (a) above, or the related components, during the
periods presented.
    (c) At the end of each reported period, provide a breakdown of the
allowance for credit losses by each loan category for which disclosure
is required by U.S. GAAP in the following format:

              Allocation of the Allowance for Credit Losses
------------------------------------------------------------------------
                                                  Reported period
                                         -------------------------------
                                                            Percent of
 Balance at End of Period Applicable to:                   loans in each
                                              Amount        category to
                                                            total loans
------------------------------------------------------------------------
Each loan category required by U.S. GAAP              $X              X%
                                         -------------------------------
                                                                    100%
------------------------------------------------------------------------

    Instructions to Item 1405:
    1. A foreign private issuer that prepares its financial statements
in accordance with IFRS as issued by the IASB does not need to provide
disclosure responsive to Items 1405(a)(2), (a)(3) and Item 1405(c).
    2. Net charge-offs must be based on current period net charge-offs
for each loan category.

Sec.  229.1406  (Item 1406) Deposits.

    (a) For each reported period, present separately the average amount
of and the average rate paid on each of the following deposit
categories that are in excess of 10 percent of average total deposits:
    (1) Noninterest bearing demand deposits.
    (2) Interest-bearing demand deposits.
    (3) Savings deposits.
    (4) Time deposits.
    (5) Other.
    (b) If the registrant believes other categories more appropriately
describe the nature of the deposits, those categories may be used.
    (c) If material, separately present domestic deposits and foreign
deposits for all amounts reported under (a) above. Foreign deposits as
used here means deposits from depositors who are not in the
registrant's country of domicile.
    (d) If material, the registrant must disclose separately the
aggregate amount of deposits by foreign depositors in domestic offices.
Registrants are not required to identify the nationality of the
depositors.
    (e) As of the end of each reported period, present separately the
amount of uninsured deposits. For registrants that are U.S. federally
insured depository institutions, uninsured deposits are the portion of
deposit accounts in U.S. offices that exceed the Federal Deposit
Insurance Corporation insurance limit or similar state deposit
insurance regime, and amounts in any other uninsured investment or
deposit accounts that are classified as deposits and not subject to any
federal or state deposit insurance regime. Foreign banking or savings
and loan registrants must disclose the definition of uninsured deposits
appropriate for their country of domicile. All registrants should
consider the methodologies and assumptions used for regulatory
reporting of uninsured deposits, to the extent applicable, for
disclosure of uninsured deposits. To the extent it is not reasonably
practicable to provide a precise measure of uninsured deposits at the
reported period, the registrant must disclose that the amounts are
based on estimated amounts of uninsured deposits as of the reported
period. Such estimates must be based on the same methodologies and
assumptions used for the applicable bank or savings and loan
registrant's regulatory reporting requirements.
    (f) As of the end of the latest reported period, state the amount
outstanding of:
    (1) The portion of U.S. time deposits, by account, that are in
excess of the Federal Deposit Insurance Corporation insurance limit or
similar state deposit insurance regime; and
    (2) Time deposits that are otherwise uninsured (including for
example, U.S. time deposits in uninsured accounts, non-U.S. time
deposits in uninsured accounts, or non-U.S. time deposits in excess of
any country-specific insurance fund limit), by time remaining until
maturity of:
    (i) 3 months or less;
    (ii) Over 3 through 6 months;
    (iii) Over 6 through 12 months; and
    (iv) Over 12 months.

PART 249--FORMS, SECURITIES EXCHANGE ACT OF 1934

0
9. The authority citation for part 249 continues to read in part as
follows:

    Authority:  15 U.S.C. 78a et seq. and 7201 et seq.; 12 U.S.C.
5461 et seq.; 18 U.S.C. 1350; Sec. 953(b) Public Law 111-203, 124
Stat. 1904; Sec. 102(a)(3), Public Law 112-106, 126 Stat. 309
(2012); Sec. 107, Public Law 112-106, 126 Stat. 313 (2012), and Sec.
72001, Public Law 114-94, 129 Stat. 1312 (2015), unless otherwise
noted.

0
10. Amend Form 20-F (referenced in Sec.  249.220f) by:
0
a. Adding Instruction 4 to Item 4; and
0
b. revising Instruction 2 to Item 7.B.
    The addition and revisions to read as follows:

    Note: The text of Form 20-F does not, and this amendment will
not, appear in the Code of Federal Regulations.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION, WASHINGTON, DC 20549

FORM 20-F

* * * * *

PART I

* * * * *
    Instructions to Item 4: * * *
    4. If you are bank, bank holding company, savings and loan
association or savings and loan holding company, provide the
information specified in Subpart 1400 of Regulation S-K (Sec.  229.1400
et seq. of this chapter).
* * * * *
    Instructions to Item 7.B: * * *
    2. In response to Item 7.B.2, if the lender is a bank, savings and
loan association, or broker dealer extending credit under Federal
Reserve Regulation T, and the loans are not disclosed as past due,
nonaccrual or troubled debt restructurings in the consolidated
financial statements, your response may consist of a statement, if
true, that the loans in question (A) were made in the ordinary course
of business, (B) were made on substantially the same terms, including
interest rates and collateral, as those prevailing at the time for
comparable transactions with other persons, and (C) did not involve
more than the normal risk of collectability or present other
unfavorable features.
* * * * *

    By the Commission.

    Dated: September 11, 2020.
Vanessa A. Countryman,
Secretary.
[FR Doc. 2020-20655 Filed 10-15-20; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 80, Number 147 (Friday, July 31, 2015)]
[Notices]
[Pages 45649-45650]
[FR Doc No: 2015-18839]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 2219-046]

Garkane Energy Cooperative, Inc.; Notice of Application Accepted
for Filing, Soliciting Comments, Motions To Intervene, and Protests

    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection:
    a. Type of Application: Request for Amendment of License.
    b. Project No.: 2219-046.
    c. Date Filed: June 29, 2015.
    d. Applicant: Garkane Energy Cooperative, Inc. (licensee).
    e. Name of Project: Boulder Creek Hydroelectric Project.
    f. Location: Garfield County, Utah.
    g. Filed Pursuant to: Federal Power Act, 16 U.S.C. 791(a)-825(r).
    h. Applicant Contact: Daniel R. Simon, Counsel for licensee, (202)
739-2813, or<EMAIL_ADDRESS>    i. FERC Contact: Erich Gaedeke,<PHONE_NUMBER>, or
<EMAIL_ADDRESS>    j. Deadline for filing comments, motions to intervene, protests,
and recommendations is 30 days from the issuance date of this notice by
the Commission.
    All documents may be filed electronically via the Internet. See, 18
CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web
site at http://www.ferc.gov/docs-filing/efiling.asp. If unable to be
filed electronically, documents may be paper-filed. To paper-file, an
original and seven copies should be mailed to: Secretary, Federal
Energy Regulatory Commission, 888 First Street NE., Washington, DC
20426. Commenters can submit brief comments up to 6,000 characters,
without prior registration, using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and
contact information at the end of your comments.
    Please include the project number (P-2219-046) on any comments,
motions, or recommendations filed.
    k. Description of Request: Due to the October 9, 2014 permanent
injunction ruling by the Sixth Judicial District Court of Garfield
County, Utah prohibiting the licensee from continuing to provide the
minimum flow releases required under U.S. Forest Service (USFS) 4(e)
Condition 14(1) due to a conflict with senior water rights, the
licensee is proposing new mitigation measures designed to replace the
Water

Release Schedule and improve Colorado River cutthroat habitat quality.
The licensee requests approval of three new mitigation measures as the
primary replacements for the Water Release Schedule stipulated under
Condition No. 14(1) of the Commission's August 31, 2007 Order Issuing
New License. Specifically, the licensee proposes to replace a culvert
crossing under USFS road 30166 to improve passage of all life stages of
Colorado River cutthroat trout; remove two fish passage barriers
located in the West Fork of Boulder Creek to improve system
connectivity with the East Fork; and install a fish trap to support a
trapping and spawning operation for native Colorado River cutthroat
trout to benefit the Project area and elsewhere within the local
watershed populations.
    l. Locations of the Application: A copy of the application is
available for inspection and reproduction at the Commission's Public
Reference Room, located at 888 First Street NE., Room 2A, Washington,
DC 20426, or by calling<PHONE_NUMBER>. This filing may also be viewed
on the Commission's Web site at http://www.ferc.gov/docs-filing/elibrary.asp. Enter the docket number excluding the last three digits
in the docket number field to access the document. You may also
register online at http://www.ferc.gov/docs-filing/esubscription.asp to
be notified via email of new filings and issuances related to this or
other pending projects. For assistance, call 1-866-208-3676 or email
<EMAIL_ADDRESS>for TTY, call<PHONE_NUMBER>. A copy is
also available for inspection and reproduction at the address in item
(h) above.
    m. Individuals desiring to be included on the Commission's mailing
list should so indicate by writing to the Secretary of the Commission.
    n. Comments, Protests, or Motions to Intervene: Anyone may submit
comments, a protest, or a motion to intervene in accordance with the
requirements of Rules of Practice and Procedure, 18 CFR 385.210, .211,
.214. In determining the appropriate action to take, the Commission
will consider all protests or other comments filed, but only those who
file a motion to intervene in accordance with the Commission's Rules
may become a party to the proceeding. Any comments, protests, or
motions to intervene must be received on or before the specified
comment date for the particular application.
    o. Filing and Service of Responsive Documents: Any filing must (1)
bear in all capital letters the title ``COMMENTS'', ``PROTEST'', or
``MOTION TO INTERVENE'' as applicable; (2) set forth in the heading the
name of the applicant and the project number of the application to
which the filing responds; (3) furnish the name, address, and telephone
number of the person protesting or intervening; and (4) otherwise
comply with the requirements of 18 CFR 385.2001 through 385.2005. All
comments, motions to intervene, or protests must set forth their
evidentiary basis and otherwise comply with the requirements of 18 CFR
4.34(b). All comments, motions to intervene, or protests should relate
to project operations, which are the subject of the variance. Agencies
may obtain copies of the application directly from the applicant. A
copy of any protest or motion to intervene must be served upon each
representative of the applicant specified in the particular
application. If an intervener files comments or documents with the
Commission relating to the merits of an issue that may affect the
responsibilities of a particular resource agency, they must also serve
a copy of the document on that resource agency. A copy of all other
filings in reference to this application must be accompanied by proof
of service on all persons listed in the service list prepared by the
Commission in this proceeding, in accordance with 18 CFR 4.34(b) and
385.2010.

    Dated: July 27, 2015.
Kimberly D. Bose,
Secretary.
[FR Doc. 2015-18839 Filed 7-30-15; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 86, Number 126 (Tuesday, July 6, 2021)]
[Notices]
[Page 35554]
[FR Doc No: 2021-14426]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meeting; Cancellation

FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: 86 FR 34080, June
28, 2021.

PREVIOUSLY ANNOUNCED TIME AND DATE OF THE MEETING: Thursday, July 1,
2021 at 2 p.m.

CHANGES IN THE MEETING: The Closed Meeting scheduled for Thursday, July
1, 2021 at 2 p.m., has been cancelled.

CONTACT PERSON FOR MORE INFORMATION: For further information; please
contact Vanessa A. Countryman from the Office of the Secretary at (202)
551-5400.

    Dated: July 1, 2021.
Vanessa A. Countryman,
Secretary.
[FR Doc. 2021-14426 Filed 7-1-21; 11:15 am]
BILLING CODE 8011-01-P


[Federal Register: April 26, 2007 (Volume 72, Number 80)]
[Notices]
[Page 20842-20843]
[DOCID:fr26ap07-51]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP06-385-001]

Western Gas Resources, Inc., and Pioneer Natural Resources (USA),
Inc.; Notice of Amendment

April 20, 2007.
    Take notice that on April 9, 2007, Pioneer Natural Resources (USA),
Inc. (Pioneer), 1400 Williams Square West, 5205 North O'Connor
Boulevard, Irving, Texas, filed an amendment to Western Gas Resources,
Inc.'s (WGR) pending May 26, 2006 application in Docket No. CP06-385-
000. By this amendment, Pioneer seeks to become a joint applicant in
the petition for clarification that the Midkiff Line, located in Texas
and jointly owned by WGR and Pioneer, retains its non-jurisdictional
status, or, alternatively, the request, pursuant to section 7(c) of the
Natural Gas Act, that the Commission issue a limited jurisdiction
certificate and waive certain regulatory requirements, all as more
fully set forth in the application which is on file with the Commission
and open for public inspection.
    This filing is accessible on-line at http://www.ferc.gov, using the

``elibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``esubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Any questions regarding this application should be directed to Mr.
Jefferson Rees, Pioneer Natural Resources, 5205 North O'Connor Blvd.,
Suite 200, Irving, Texas 75039; or e-mail<EMAIL_ADDRESS>phone:
(972) 969-4040; or fax:<PHONE_NUMBER>.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the

appropriate action to be taken, but will not serve to make protestants
parties to the proceeding. Any person wishing to become a party must
file a notice of intervention or motion to intervene, as appropriate.
Such notices, motions, or protests must be filed on or before the
comment date indicated below. Anyone filing a motion to intervene or
protest must serve a copy of that document on the Applicant. On or
before the comment date, it is not necessary to serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``efiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    Comment Date: May 11, 2007.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-7989 Filed 4-25-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 214 (Tuesday, November 7, 2017)]
[Rules and Regulations]
[Pages 51558-51560]
[FR Doc No: 2017-24161]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 862

[Docket No. FDA-2017-N-4394]

Medical Devices; Clinical Chemistry and Clinical Toxicology
Devices; Classification of the Total 25-Hydroxyvitamin D Mass
Spectrometry Test System

AGENCY: Food and Drug Administration, HHS.

ACTION: Final order.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is
classifying the total 25-hydroxyvitamin D mass spectrometry test system
into class II (special controls). The special controls that apply to
the device type are identified in this order and will be part of the
codified language for the total 25-hydroxyvitamin D mass spectrometry
test system's classification. We are taking this action because we have
determined that classifying the device into class II (special controls)
will provide a reasonable assurance of safety and effectiveness of the
device. We believe this action will also enhance patients' access to
beneficial innovative devices, in part by reducing regulatory burdens.

DATES: This order is effective November 7, 2017. The classification was
applicable on May 18, 2017.

FOR FURTHER INFORMATION CONTACT: Steven Tjoe, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 4550, Silver Spring, MD 20993-0002,<PHONE_NUMBER>,
[email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    Upon request, FDA has classified the total 25-hydroxyvitamin D mass
spectrometry test system as class II (special controls), which we have
determined will provide a reasonable assurance of safety and
effectiveness. In addition, we believe this action will enhance
patients' access to beneficial innovation, in part by reducing
regulatory burdens by placing the device into a lower device class than
the automatic class III assignment.
    The automatic assignment of class III occurs by operation of law
and without any action by FDA, regardless of the level of risk posed by
the new device. Any device that was not in commercial distribution
before May 28, 1976, is automatically classified as, and remains
within, class III and requires premarket approval unless and until FDA
takes an action to classify or reclassify the device (see 21 U.S.C.
360c(f)(1)). We refer to these devices as ``postamendments devices''
because they were not in commercial distribution prior to the date of
enactment of the Medical Device Amendments of 1976, which amended the
Federal Food, Drug, and Cosmetic Act (the FD&C Act).
    FDA may take a variety of actions in appropriate circumstances to
classify or reclassify a device into class I or II. We may issue an
order finding a new device to be substantially equivalent under section
513(i) of the FD&C Act to a predicate device that does not require
premarket approval (see 21 U.S.C. 360c(i)). We determine whether a new
device is substantially equivalent to a predicate by means of the
procedures for premarket notification under section 510(k) of the FD&C
Act and part 807 (21 U.S.C. 360(k) and 21 CFR part 807, respectively).
    FDA may also classify a device through ``De Novo'' classification,
a common name for the process authorized under section 513(f)(2) of the
FD&C Act. Section 207 of the Food and Drug Administration Modernization
Act of 1997 established the first procedure for De Novo classification
(Pub. L. 105-115). Section 607 of the Food and Drug Administration
Safety and Innovation Act modified the De Novo application process by
adding a second procedure (Pub. L. 112-144). A device sponsor may
utilize either procedure for De Novo classification.
    Under the first procedure, the person submits a 510(k) for a device
that has not previously been classified. After receiving an order from
FDA classifying the device into class III under section 513(f)(1) of
the FD&C Act, the person then requests a classification under section
513(f)(2).
    Under the second procedure, rather than first submitting a 510(k)
and then a request for classification, if the person determines that
there is no legally marketed device upon which to base a determination
of substantial equivalence, that person requests a classification under
section 513(f)(2) of the FD&C Act.
    Under either procedure for De Novo classification, FDA is required
to classify the device by written order within 120 days. The
classification will be according to the criteria under section
513(a)(1) of the FD&C Act. Although the device was automatically within
class III, the De Novo classification is considered to be the initial
classification of the device.
    We believe this De Novo classification will enhance patients'
access to beneficial innovation, in part by reducing regulatory
burdens. When FDA classifies a device into class I or II via the De
Novo process, the device can serve as a predicate for future devices of
that type, including for 510(k)s (see 21 U.S.C. 360c(f)(2)(B)(i)). As a
result, other device sponsors do not have to submit a De Novo request
or PMA in order to market a substantially equivalent device (see 21
U.S.C. 360c(i), defining ``substantial equivalence''). Instead,
sponsors can use the less-burdensome 510(k) process, when necessary, to
market their device.

II. De Novo Classification

    On March 20, 2017, AB Sciex LLC submitted a request for De Novo
classification of the Vitamin D 200M Assay for the Topaz System. FDA
reviewed the request in order to classify the device under the criteria
for classification set forth in section 513(a)(1) of the FD&C Act.
    We classify devices into class II if general controls by themselves
are insufficient to provide reasonable assurance of safety and
effectiveness, but there is sufficient information to establish special
controls that, in combination with the generals controls, provide
reasonable assurance of the safety and effectiveness of the device for
its intended use (see 21 U.S.C. 360c(a)(1)(B)). After review of the
information submitted in the request, we determined that the device can
be classified into class II with the establishment of special controls.
FDA has determined that these special controls, in addition to the
general controls, will provide reasonable

assurance of the safety and effectiveness of the device.
    Therefore, on May 18, 2017, FDA issued an order to the requester
classifying the device into class II. FDA is codifying the
classification of the device by adding 21 CFR 862.1840. We have named
the generic type of device total 25-hydroxyvitamin D mass spectrometry
test system, and it is identified as a device intended for use in
clinical laboratories for the quantitative determination of total 25-
hydroxyvitamin D (25-OH-D) in serum or plasma to be used in the
assessment of vitamin D sufficiency.
    FDA has identified the following risks to health associated
specifically with this type of device and the measures required to
mitigate these risks in table 1.

 Table 1--Total 25-hydroxyvitamin D Mass Spectrometry Test System Risks
                         and Mitigation Measures
------------------------------------------------------------------------
            Identified risk                    Mitigation measures
------------------------------------------------------------------------
Clinical action based on falsely         General controls; Special
 elevated inaccurate Vitamin D results    control (1) (21 CFR
 may lead to unnecessary                  862.1840(b)(1)); and, Special
 supplementation of Vitamin D.            control (2) (21 CFR
                                          862.1840(b)(2)).
Clinical action based on falsely low     General controls; Special
 inaccurate Vitamin D results may lead    control (1) (21 CFR
 to a delay in supplementation of         862.1840(b)(1)); and, Special
 Vitamin D.                               control (2) (21 CFR
                                          862.1840(b)(2)).
Clinical action based on                 General controls; and, Special
 uninterpretable results due to lack of   control (3) (21 CFR
 established device specific reference    862.1840(b)(3)).
 range values for the representative
 population.
Clinical action based on the             General controls; and, Special
 misinterpretation of Vitamin D2 or       control (4) (21 CFR
 Vitamin D3 results as total Vitamin D    862.1840(b)(4)).
 results.
------------------------------------------------------------------------

    FDA has determined that special controls, in combination with the
general controls, address these risks to health and provide reasonable
assurance of safety and effectiveness. In order for a device to fall
within this classification, and thus avoid automatic classification in
class III, it would have to comply with the special controls named in
this final order. The necessary special controls appear in the
regulation codified by this order. This device is subject to premarket
notification requirements under section 510(k).
    Section 510(m)(2) of the FD&C Act provides that FDA may exempt a
class II device from the premarket notification requirements under
section 510(k) if, after notice of our intent to exempt and
consideration of comments, we determine by order that premarket
notification is not necessary to provide reasonable assurance of safety
and effectiveness of the device. We believe this may be such a device.
The notice of intent to exempt the device from premarket notification
requirements is published elsewhere in this issue of the Federal
Register.

III. Analysis of Environmental Impact

    The Agency has determined under 21 CFR 25.34(b) that this action is
of a type that does not individually or cumulatively have a significant
effect on the human environment. Therefore, neither an environmental
assessment nor an environmental impact statement is required.

IV. Paperwork Reduction Act of 1995

    This final order establishes special controls that refer to
previously approved collections of information found in other FDA
regulations. These collections of information are subject to review by
the Office of Management and Budget (OMB) under the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501-3520). The collections of information in
part 807, subpart E, regarding premarket notification submissions have
been approved under OMB control number 0910-0120, and the collections
of information in 21 CFR parts 801 and 809, regarding labeling have
been approved under OMB control number 0910-0485.

List of Subjects in 21 CFR Part 862

    Medical devices.

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, 21 CFR part
862 is amended as follows:

PART 862--CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES

0
1. The authority citation for part 862 continues to read as follows:

    Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 360l, 371.

0
2. Add Sec.  862.1840 to subpart B to read as follows:

Sec.  862.1840  Total 25-hydroxyvitamin D mass spectrometry test
system.

    (a) Identification. A total 25-hydroxyvitamin D mass spectrometry
test system is a device intended for use in clinical laboratories for
the quantitative determination of total 25-hydroxyvitamin D (25-OH-D)
in serum or plasma to be used in the assessment of vitamin D
sufficiency.
    (b) Classification. Class II (special controls). The special
controls for this device are:
    (1) The device must have initial and annual standardization
verification by a certifying vitamin D standardization organization
deemed acceptable by FDA.
    (2) The 21 CFR 809.10(b) compliant labeling must include detailed
descriptions of performance testing conducted to evaluate precision,
accuracy, linearity, interference, including the following:
    (i) Performance testing of device precision must, at a minimum, use
intended sample type with Vitamin D concentrations at medically
relevant decision points. At least one sample in the precision studies
must be an unmodified patient sample. This testing must evaluate
repeatability and reproducibility using a protocol from an FDA-
recognized standard.
    (ii) Performance testing of device accuracy must include a minimum
of 115 serum or plasma samples that span the measuring interval of the
device and compare results of the new device to results of a reference
method or a legally marketed standardized mass spectrometry based
vitamin D assay. The results must be described in the 21 CFR
809.10(b)(12) compliant labeling of the device.
    (iii) Interference from vitamin D analogs and metabolites including
vitamin D2, vitamin D3, 1-hydroxyvitamin D2, 1-hydroxyvitamin D3, 3-
Epi-25-Hydroxyvitamin D2, 3-Epi-25-Hydroxyvitamin D3, 1,25-
Dihydroxyvitamin D2, 1,25-Dihydroxyvitamin D3, 3-Epi-1,25-
Dihydroxyvitamin D2, and 3-Epi-1,25-Dihydroxyvitamin D3, 25, 26-
Dihydroxyvitamin-D3, 24 (R), 25-dihydroxyvitamin-D3, 23 (R), 25-
dihydroxyvitamin-D3 must be described in the 21 CFR 809.10(b)(7)
compliant labeling of the device.
    (3) The 21 CFR 809.10(b) compliant labeling must be supported by a
reference range study representative of

the performance of the device. The study must be conducted using
samples collected from apparently healthy male and female adults at
least 21 years of age and older from at least 3 distinct climatic
regions within the United States in different weather seasons. The
ethnic, racial, and gender background of this study population must be
representative of the U.S. population demographics.
    (4) The results of the device as provided in the 21 CFR 809.10(b)
compliant labeling and any test report generated must be reported as
only total 25-hydroxyvitamin D.

    Dated: October 31, 2017.
Lauren Silvis,
Chief of Staff.
[FR Doc. 2017-24161 Filed 11-6-17; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 87, Number 231 (Friday, December 2, 2022)]
[Proposed Rules]
[Pages 74048-74049]
[FR Doc No: 2022-26141]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2022-1444; Airspace Docket No. 22-AWP-74]
RIN 2120-AA66

Proposed Establishment of Class E Airspace; Williams, AZ

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: This action proposes to establish Class E airspace at
Williams, AZ. The FAA is proposing this action to support the
establishment of new public instrument procedures.

DATES: Comments must be received on or before January 17, 2023.

ADDRESSES: Send comments on this proposal to the U.S. Department of
Transportation, Docket Operations, West Building Ground Floor, Room
W12-140, 1200 New Jersey Avenue SE, Washington, DC 20590; telephone
(202) 366-9826, or<PHONE_NUMBER>. You must identify FAA Docket No.
FAA-2022-1444/Airspace Docket No. 22-AWP-74 at the beginning of your
comments. You may also submit comments through the internet at
www.regulations.gov. You may review the public docket containing the
proposal, any comments received, and any final disposition in person in
the Dockets Office between 9:00 a.m. and 5:00 p.m., Monday through
Friday, except federal holidays.
    FAA Order JO 7400.11G, Airspace Designations and Reporting Points,
and subsequent amendments can be viewed online at www.faa.gov/air_traffic/publications/. For further information, you can contact the
Airspace Policy Group, Federal Aviation Administration, 800
Independence Avenue SW, Washington, DC 20591; telephone: (202) 267-
8783.

FOR FURTHER INFORMATION CONTACT: Jeffrey Claypool, Federal Aviation
Administration, Operations Support Group, Central Service Center, 10101
Hillwood Parkway, Fort Worth, TX 76177; telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Authority for This Rulemaking

    The FAA's authority to issue rules regarding aviation safety is
found in Title 49 of the United States Code. Subtitle I, Section 106
describes the authority of the FAA Administrator. Subtitle VII,
Aviation Programs, describes in more detail the scope of the agency's
authority. This rulemaking is promulgated under the authority described
in Subtitle VII, Part A, Subpart I, Section 40103. Under that section,
the FAA is charged with prescribing regulations to assign the use of
airspace necessary to ensure the safety of aircraft and the efficient
use of airspace. This regulation is within the scope of that authority
as it would establish Class E airspace extending upward form 700 feet
above the surface at H.A. Clark Memorial Field, Williams, AZ, to
support instrument flight rule operations at this airport.

Comments Invited

    Interested parties are invited to participate in this proposed
rulemaking by submitting such written data, views, or arguments, as
they may desire. Comments that provide the factual basis supporting the
views and suggestions presented are particularly helpful in developing
reasoned regulatory decisions on the proposal. Comments are
specifically invited on the overall regulatory, aeronautical, economic,
environmental, and energy-related aspects of the proposal.
Communications should identify both docket numbers and be submitted in
triplicate to the address listed above. Commenters wishing the FAA to
acknowledge receipt of their comments on this notice must submit with
those comments a self-addressed, stamped postcard on which the
following statement is made: ``Comments to Docket No. FAA-2022-1444/
Airspace Docket No. 22-AWP-74.'' The postcard will be date/time stamped
and returned to the commenter.
    All communications received before the specified closing date for
comments will be considered before taking action on the proposed rule.
The proposal contained in this notice may be changed in light of the
comments received. A report summarizing each substantive public contact
with FAA personnel concerned with this rulemaking will be filed in the
docket.

Availability of NPRMs

    An electronic copy of this document may be downloaded through the
internet at www.regulations.gov. Recently published rulemaking
documents can also be accessed through the FAA's web page at
www.faa.gov/air_traffic/publications/airspace_amendments/.
    You may review the public docket containing the proposal, any
comments received, and any final disposition in person in the Dockets
Office (see the ADDRESSES section for the address and phone number)
between 9:00 a.m. and 5:00 p.m., Monday through Friday, except federal
holidays. An informal docket may also be examined during normal
business hours at the Federal Aviation Administration, Air Traffic
Organization, Central Service Center, Operations Support Group, 10101
Hillwood Parkway, Fort Worth, TX 76177.

Availability and Summary of Documents for Incorporation by Reference

    This document proposes to amend FAA Order JO 7400.11G, Airspace
Designations and Reporting Points, dated August 19, 2022, and effective
September 15, 2022. FAA Order JO 7400.11G is publicly available as
listed in the ADDRESSES section of this document. FAA Order JO 7400.11G
lists Class A, B, C, D, and E airspace areas, air traffic service
routes, and reporting points.

The Proposal

    The FAA is proposing an amendment to 14 CFR part 71 by establishing
Class E airspace extending upward from 700 feet above the surface
within a 20-mile radius of H.A. Clark Memorial Field, Williams, AZ.
    This action supports the establishment of public instrument
procedures at H.A. Clark Memorial Field.
    Class E airspace designations are published in paragraph 6005 of
FAA Order JO 7400.11G, dated August 19, 2022, and effective September
15, 2022,

which is incorporated by reference in 14 CFR 71.1. The Class E airspace
designations listed in this document will be published subsequently in
FAA Order JO 7400.11.
    FAA Order JO 7400.11, Airspace Designations and Reporting Points,
is published yearly and effective on September 15.

Regulatory Notices and Analyses

    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current, is
non-controversial and unlikely to result in adverse or negative
comments. It, therefore: (1) is not a ``significant regulatory action''
under Executive Order 12866; (2) is not a ``significant rule'' under
DOT Regulatory Policies and Procedures (44 FR 11034; February 26,
1979); and (3) does not warrant preparation of a regulatory evaluation
as the anticipated impact is so minimal. Since this is a routine matter
that will only affect air traffic procedures and air navigation, it is
certified that this rule, when promulgated, would not have a
significant economic impact on a substantial number of small entities
under the criteria of the Regulatory Flexibility Act.

Environmental Review

    This proposal will be subject to an environmental analysis in
accordance with FAA Order 1050.1F, ``Environmental Impacts: Policies
and Procedures'' prior to any FAA final regulatory action.

List of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

The Proposed Amendment

    Accordingly, pursuant to the authority delegated to me, the Federal
Aviation Administration proposes to amend 14 CFR part 71 as follows:

PART 71--DESIGNATION OF CLASS A, B, C, D, AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND REPORTING POINTS

0
1. The authority citation for 14 CFR part 71 continues to read as
follows:

    Authority: 49 U.S.C. 106(f), 106(g); 40103, 40113, 40120; E.O.
10854, 24 FR 9565, 3 CFR, 1959-1963 Comp., p. 389.

Sec.  71.1  [Amended]

0
2. The incorporation by reference in 14 CFR 71.1 of FAA Order JO
7400.11G, Airspace Designations and Reporting Points, dated August 19,
2022, and effective September 15, 2022, is amended as follows:

Paragraph 6005 Class E Airspace Areas Extending Upward From 700
Feet or More Above the Surface of the Earth.

* * * * *

AWP AZ E5 Williams, AZ [Establish]

H.A. Clark Memorial Field, AZ
    (Lat. 35[deg]18'20'' N, long. 112[deg]11'40'' W)

    That airspace extending upward from 700 feet above the surface
within a 20-mile radius of H.A. Clark Memorial Field.

    Issued in Fort Worth, Texas, on November 28, 2022.
Steven T. Phillips,
Acting Manager, Operations Support Group, ATO Central Service Center.
[FR Doc. 2022-26141 Filed 12-1-22; 8:45 am]
BILLING CODE 4910-13-P